Actinium Pharmaceuticals, Inc. (ATNM) DCF Valuation

Valoración de DCF de Actinium Pharmaceuticals, Inc. (ATNM)

US | Healthcare | Biotechnology | AMEX
Actinium Pharmaceuticals, Inc. (ATNM) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Actinium Pharmaceuticals, Inc. (ATNM) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus opciones de inversión con la calculadora DCF (ATNM)! Utilice las finanzas de actinio precisas, ajuste las proyecciones y gastos de crecimiento, y observe cómo estas modificaciones afectan el valor intrínseco de (ATNM) en tiempo real.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 1.1 1.0 .1 .1 .0 .0 .0 .0
Revenue Growth, % 0 0 0 -9.97 -92.14 -25.53 -25.53 -25.53 -25.53 -25.53
EBITDA -21.5 -21.8 -24.4 -33.4 -51.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 -2136.36 -3243.2 -63123.46 -20 -20 -20 -20 -20
Depreciation .4 .4 .5 .7 .8 .0 .0 .0 .0 .0
Depreciation, % 100 100 45.8 67.86 975.31 82.73 82.73 82.73 82.73 82.73
EBIT -21.9 -22.2 -25.0 -34.1 -51.9 .0 .0 .0 .0 .0
EBIT, % 100 100 -2182.17 -3311.07 -64098.77 -20 -20 -20 -20 -20
Total Cash 9.3 63.6 77.8 108.9 76.7 .1 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .1 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 0 0 0
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 0 0 0 40 40 40 40 40
Accounts Payable 4.6 4.3 5.5 10.1 8.0 .1 .0 .0 .0 .0
Accounts Payable, % 100 100 483.83 983.5 9818.52 100 100 100 100 100
Capital Expenditure -.1 -.3 -.1 -.4 -.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 -11.63 -35.53 -188.89 -29.43 -29.43 -29.43 -29.43 -29.43
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -21.7 -22.0 -24.8 -33.0 -51.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -16.8 -22.1 -23.2 -28.1 -53.5 -7.9 .0 .0 .0 .0
WACC, % 5.33 5.33 5.33 5.33 5.34 5.33 5.33 5.33 5.33 5.33
PV UFCF
SUM PV UFCF -7.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -7
Net Debt -75
Equity Value 67
Diluted Shares Outstanding, MM 27
Equity Value Per Share 2.53

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to generate various scenarios.
  • Real-World Data: Actinium Pharmaceuticals, Inc.'s (ATNM) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.

Key Features

  • Comprehensive ATNM Data: Pre-loaded with Actinium Pharmaceuticals’ historical performance metrics and future projections.
  • Customizable Assumptions: Modify key variables such as revenue growth, profit margins, discount rates, tax implications, and capital investments.
  • Interactive Valuation Framework: Real-time calculations of Net Present Value (NPV) and intrinsic worth based on your selected parameters.
  • Scenario Analysis: Develop various forecasting scenarios to evaluate different potential valuation results.
  • Intuitive Interface: Clean, organized, and tailored for both seasoned professionals and newcomers.

How It Works

  1. Step 1: Download the Excel file for Actinium Pharmaceuticals, Inc. (ATNM).
  2. Step 2: Review the pre-filled financial data and forecasts specific to Actinium Pharmaceuticals.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you modify your assumptions.
  5. Step 5: Evaluate the outputs and utilize the results for your investment strategies.

Why Choose This Calculator for Actinium Pharmaceuticals, Inc. (ATNM)?

  • Accurate Data: Utilize real Actinium financials for dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Built-in calculations remove the necessity to start from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the pharmaceutical sector.
  • User-Friendly: Easy-to-navigate design and detailed instructions ensure accessibility for all users.

Who Should Use Actinium Pharmaceuticals, Inc. (ATNM)?

  • Investors: Gain insights into the biopharmaceutical market with a reliable evaluation tool tailored for Actinium Pharmaceuticals, Inc. (ATNM).
  • Financial Analysts: Streamline your analysis with a comprehensive financial model specifically designed for the biotech sector.
  • Consultants: Effortlessly modify the template for client engagements or industry reports focused on Actinium Pharmaceuticals, Inc. (ATNM).
  • Healthcare Enthusiasts: Enhance your knowledge of biopharmaceutical valuation methods through practical applications and case studies.
  • Educators and Students: Utilize it as a hands-on resource in courses related to finance and healthcare investments.

What the Template Contains

  • Pre-Filled Data: Includes Actinium Pharmaceuticals’ historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Actinium Pharmaceuticals’ profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.